Germán Santiago J, Zamora N, de la Rosa E, Alba Carrión C, Padrón P, Hernández M, Betancourt M, Moretti N
División de Producción de Vacunas Bacterianas, Instituto Nacional de Higiene Rafael Rangel, Caracas, Venezuela.
Acta Cient Venez. 1995;46(2):129-34.
The production of Pertussis Vaccine was reevaluated at the Instituto Nacional de Higiene "Rafael Rangel" in order to optimise it in terms of vaccine yield, potency, specific toxicity and efficiency (cost per doses). Four different processes, using two culture media (Cohen-Wheeler and Fermentación Glutamato Prolina-1) and two types of bioreactors (25 L Fermentador Caracas and a 450 L industrial fermentor) were compared. Runs were started from freeze-dried strains (134 or 509) and continued until the obtention of the maximal yield. It was found that the combination Fermentación Glutamato Prolina-1/industrial fermentor, shortened the process to 40 hours while consistently yielding a vaccine of higher potency (7.91 +/- 2.56 IU/human dose) and lower specific toxicity in a mice bioassay. In addition, the physical aspect of the preparation was rather homogeneous and free of dark aggregates. Most importantly, the biomass yield more than doubled those of the Fermentador Caracas using the two different media and that in the industrial fermentor with the Cohen-Wheeler medium. Therefore, the cost per doses was substantially decreased.
为了在疫苗产量、效力、特定毒性和效率(每剂成本)方面对百日咳疫苗进行优化,委内瑞拉国家卫生研究院“拉斐尔·兰赫尔”对百日咳疫苗的生产进行了重新评估。比较了使用两种培养基(科恩 - 惠勒培养基和谷氨酸 - 脯氨酸 - 1发酵培养基)和两种生物反应器(25升加拉加斯发酵罐和450升工业发酵罐)的四种不同工艺。从冻干菌株(134或509)开始运行,持续到获得最大产量。结果发现,谷氨酸 - 脯氨酸 - 1发酵培养基/工业发酵罐的组合将生产过程缩短至40小时,同时在小鼠生物测定中始终产生效力更高(7.91±2.56国际单位/人剂量)且特定毒性更低的疫苗。此外,制剂的物理外观相当均匀,没有深色聚集体。最重要的是,使用两种不同培养基时,工业发酵罐中生物量产量比加拉加斯发酵罐增加了一倍多,且在使用科恩 - 惠勒培养基的工业发酵罐中生物量产量也大幅增加。因此,每剂成本大幅降低。